Department of Infectious Diseases and Infection Control, Cantonal Hospital St. Gallen, 9007, St. Gallen, Switzerland.
Infection. 2013 Feb;41(1):33-40. doi: 10.1007/s15010-012-0290-1. Epub 2012 Jul 11.
Methicillin-resistant Staphylococcus aureus (MRSA) decolonization is a widely established, though controversial part of many MRSA controlling strategies. The aim of this study was to evaluate our decolonization success rate, identify the risk factors for decolonization failure and determine the optimal duration of follow-up in our low MRSA prevalence setting (2.6 % of isolates).
Every patient with newly detected MRSA colonization or infection between January 2007 and December 2009 was recruited to the study. The MRSA strategy of our institution (a 700 bed tertiary hospital in eastern Switzerland) consists of a 5-day regimen of nasal mupirocin ointment, chlorhexidin mouth rinse and whole body wash with didecyldimonium chloride. Systemic antibiotics are usually not added to the regimen.
We determined a MRSA decolonization success rate of 65 % (33/51) after a median follow-up of 13 months [i.e. a tripling of the spontaneous clearance rate of 22 % (6/27) in the non-decolonized group]. The most important risk factor for decolonization failure was colonization of the respiratory tract [odds risk (OR) 9.1, 95 % confidence interval (CI) 1.2-66.7], as well as isolation of MRSA spa-type 002 ([R 5.8, 95 % CI 1.0-33.3). Of all the episodes of MRSA recurrence, 88 % (14/16) were detected within 270 days after decolonization.
High MRSA decolonization success rates can be achieved without the routine use of oral antibiotics. A time period of 1 year after decolonization seems to be a reasonable duration of follow-up in our setting. We encourage other institutions to take into account local MRSA epidemiology (e.g. predominance of certain subtypes) for the management of MRSA patients.
耐甲氧西林金黄色葡萄球菌(MRSA)去定植是许多 MRSA 控制策略的重要组成部分,但仍存在争议。本研究旨在评估我们的去定植成功率,确定去定植失败的危险因素,并确定我们所处的低 MRSA 流行环境(分离株的 2.6%)下的最佳随访时间。
我们招募了 2007 年 1 月至 2009 年 12 月期间新检出的 MRSA 定植或感染患者。我们机构的 MRSA 策略包括 5 天的鼻腔莫匹罗星软膏、洗必泰口腔漱口液和双癸基二甲基氯化铵全身沐浴。通常不向方案中添加全身性抗生素。
我们在中位随访 13 个月后确定了 65%(33/51)的 MRSA 去定植成功率[即在未去定植组中,自发清除率从 22%(6/27)增加了两倍]。去定植失败的最重要危险因素是呼吸道定植(比值比[OR]9.1,95%置信区间[CI]1.2-66.7),以及分离出 MRSA spa 型 002([RR 5.8,95%CI 1.0-33.3)。在所有的 MRSA 复发病例中,88%(14/16)在去定植后 270 天内被检出。
在不常规使用口服抗生素的情况下,可实现高的 MRSA 去定植成功率。在我们的环境中,去定植后 1 年似乎是一个合理的随访时间。我们鼓励其他机构考虑当地的 MRSA 流行病学(例如,某些亚型的优势)来管理 MRSA 患者。